Canaccord Genuity Downgrades Botanix Pharmaceuticals
Canaccord Genuity has downgraded Botanix Pharmaceuticals from a 'Buy' to a 'Hold' rating.
Stocks · News reference
Wall Street analysts upgraded Grocery Outlet, NICE and Pinnacle Financial Partners; targets are $15, $150 and $118, respectively.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Canaccord Genuity has downgraded Botanix Pharmaceuticals from a 'Buy' to a 'Hold' rating.
Canaccord Genuity has revised its price target for Regeneron Pharmaceuticals, increasing it from $875 to $922.
UBS has revised its price target for CF Industries Holdings, Inc. from $123 to $134 while maintaining a Neutral rating.
Grocery Outlet Holding Corp. has scheduled the release of its third quarter fiscal 2026 financial results for November 10, 2026, followed by a conference call.
Analysts revised targets and ratings for KMX, ARX, JKHY, MRNA, GO, HNGE, AYTU and MSFT, with mixed upgrades, downgrades and reiterations.